Related Experiment Video
Updated: Apr 16, 2026
09:52
Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
Published on: April 19, 2013
25.0K
Single nucleotide polymorphisms in type 2 diabetes among Hispanic adults
Amanda L Watson1, Jie Hu2, Norman H L Chiu3
1Department of Chemistry and Biochemistry, University of North Carolina at Greensboro, Greensboro, NC 27412, USA.
Diabetes Research and Clinical Practice
|March 16, 2015
Summary
This study identified 26 novel genetic variations linked to type 2 diabetes (T2D) in Hispanic adults. These genetic markers, or single nucleotide polymorphisms (SNPs), could help distinguish between diabetic and non-diabetic individuals.
Area of Science:
- Genetics
- Metabolic Diseases
- Population Health
Background:
- Type 2 diabetes (T2D) poses a significant health burden, particularly in Hispanic populations.
- Understanding the genetic underpinnings of T2D is crucial for developing targeted interventions.
- Existing research has not fully elucidated the genetic factors contributing to T2D in Hispanic adults.
Purpose of the Study:
- To investigate genetic variations associated with type 2 diabetes (T2D) in a cohort of Hispanic adults.
- To identify novel single nucleotide polymorphisms (SNPs) linked to T2D susceptibility within this demographic.
- To explore the potential of identified genetic markers for differentiating T2D cases from controls.
Main Methods:
- Genotyping of 36 Hispanic adults using the Cardio-Metabochip.
- Analysis of single nucleotide polymorphisms (SNPs) for association with T2D.
- Application of principal component analysis (PCA) on 26 identified SNPs to assess sample differentiation.
Main Results:
- A total of 26 single nucleotide polymorphisms (SNPs) were found to be associated with T2D in the study cohort.
- None of the identified SNPs have been previously reported in relation to T2D.
- Principal component analysis successfully distinguished between samples from diabetic patients and control individuals based on the 26 SNPs.
Conclusions:
- The study provides evidence for the involvement of specific genetic factors in the development of T2D among Hispanic adults.
- The identified novel SNPs represent potential biomarkers for T2D risk and diagnosis in this population.
- Further research is warranted to validate these findings and explore the functional roles of the associated genetic variations.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
5.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.9K
01:27Principles of Pharmacogenetics: Types of Genetic Variants
119
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
119
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.9K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.9K
01:22Diabetes Mellitus: Overview and Type I Subtype
6.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.4K
01:05Single Nucleotide Polymorphisms-SNPs
20.2K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
20.2K
01:29Pharmacogenomics: Identification of New Drug Targets
94
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
94